Clinical trial
Sigi Insulin Management System - First-in-Human Study
NCT05973422 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sigi Insulin Management System - First-in-Human Study
- Lead sponsor
- Tandem Diabetes Care, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2024
- Completion date
- September 30, 2024
- Enrollment
- 10 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes